View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 29, 2022
1 min read
Save

Conscious sedation no better than general anesthesia in post-stroke endovascular treatment

Conscious sedation no better than general anesthesia in post-stroke endovascular treatment

Conscious sedation was not superior to general anesthesia for functional recovery in patients undergoing endovascular treatment following acute posterior circulation stroke, researchers reported in JAMA Neurology.

SPONSORED CONTENT
September 29, 2022
2 min read
Save

Healthy habits in midlife may help delay onset of cognitive decline

Healthy habits in midlife may help delay onset of cognitive decline

LAS VEGAS — To slow or stave off symptoms relating to Alzheimer’s disease and dementia, individuals should make healthy habits a priority early in life, according to a presenter at BRAINWeek 2022.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
September 28, 2022
2 min read
Save

PD therapy for off time depends on safety, efficacy, patient preference

PD therapy for off time depends on safety, efficacy, patient preference

LAS VEGAS — When evaluating the best choice for on-demand therapies for off time in Parkinson’s disease, physicians should consider severity of side effects, time to efficacy and patient preference, a presenter stated at BRAINWeek 2022.

SPONSORED CONTENT
September 28, 2022
1 min read
Save

Phase 3 study of lecanemab shows reduction in clinical decline in patients with early AD

Phase 3 study of lecanemab shows reduction in clinical decline in patients with early AD

Pharmaceutical companies Biogen and Eisai announced results from a phase 3 trial that demonstrated treatment with lecanemab reduced cognitive decline by 27% after 18 months compared with placebo.

SPONSORED CONTENT
September 27, 2022
1 min read
Save

International Parkinson’s study to explore risk prediction of neurodegenerative diseases

International Parkinson’s study to explore risk prediction of neurodegenerative diseases

The National Center of Excellence in Research on Parkinson’s Disease in Luxembourg has launched an online survey in collaboration with regional research centers to improve risk prediction for neurodegenerative diseases.

SPONSORED CONTENT
September 27, 2022
1 min read
Save

Monkeypox should be considered in high-risk populations with neurologic symptoms

Monkeypox should be considered in high-risk populations with neurologic symptoms

Monkeypox should be considered in high-risk populations who present with neurologic symptoms, warranting the need for serology and PCR testing of blood and spinal fluid, researchers wrote in JAMA Neurology.

SPONSORED CONTENT
September 27, 2022
1 min read
Save

Majority of small business owners prioritize mental health since onset of pandemic

Majority of small business owners prioritize mental health since onset of pandemic

Results of a recently released poll revealed that 77% of small business owners said they have prioritized mental health since the onset of the COVID-19 pandemic.

SPONSORED CONTENT
September 26, 2022
1 min read
Save

Rituximab reduced risk for disease worsening in generalized myasthenia gravis

A single, 500 mg dose of rituximab was associated with greater probability of minimal myasthenia gravis manifestations and reduced the need for rescue medications compared with placebo, researchers reported in JAMA Neurology.

SPONSORED CONTENT
September 26, 2022
2 min read
Save

Multimorbidity associated with increased risk for dementia

Multimorbidity associated with increased risk for dementia

Multimorbidity was associated with a 63% increased risk for incident dementia, with the greatest risk linked to hypertension and diabetes, researchers reported in JAMA Network Open.

SPONSORED CONTENT
September 23, 2022
1 min read
Save

NIH awards UCLA $10M to study brain’s cellular infrastructure

NIH awards UCLA $10M to study brain’s cellular infrastructure

The NIH has awarded nearly $10 million to two scientists at UCLA’s David Geffen School of Medicine for research projects that aim to shed light on the development of the brain’s cellular infrastructure as well as brain disorders.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails